Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer Animal Health and Jilin Guoyuan Animal Health have joined hands to manufacture, develop and distribute animal health vaccines in China.
Subscribe to our email newsletter
The new joint venture company – Jilin Pfizer Guoyuan Animal Health – will initially be responsible to develop vaccines to protect the health of swine.
Jilin Guoyuan Animal Health GM Hua Wu said the new joint venture begins operations from a position of strength.
"Pfizer complements Guoyuan with its R&D, manufacturing, regulatory and operational expertise, its founding leadership in the International Veterinary Collaboration for China, a Veterinary Alliance, as well as its growing field force and customer base in China," Wu said.
The joint venture is subject to approval by government authorities in China.